Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

UK ‘less prepared for a pandemic now than before Covid’

by March 24, 2023
March 24, 2023
UK ‘less prepared for a pandemic now than before Covid’

Britain is less prepared for a pandemic now than it was three years ago, thanks to the sale of a key vaccine manufacturing plant, leading scientists have warned.

Professor Adrian Hill, director of the Jenner Institute, which was responsible for the Oxford Covid vaccine, said that the recent loss of the Vaccines Manufacturing and Innovation Centre (VMIC) in Oxfordshire, which had been created to respond to outbreaks, showed that the UK had been going backwards since the coronavirus pandemic.

“It’s less that we haven’t learnt the lessons — we’re aware of the lessons,” he said. “We just haven’t taken the action that’s required from those lessons. And we’re looking at our toes again, rather than doing something about it.”

The £200 million tax-payer-funded facility was set up as a not-for-profit company, partly in response to the 2014 Ebola outbreak. It was intended to help vaccines from a diverse set of technologies into manufacturing and quickly increase production during pandemics.

When the coronavirus struck, the facility was repurposed with a view to mass manufacture but, now that the vaccines are being made by pharmaceutical companies, it has been sold to a US company. This means that the UK is once again without a flexible manufacturing facility that can respond to outbreaks. The government has argued that the sale helps to strengthen UK biotherapeutics.

Hill said the loss of control was baffling. “The man in the street thinks the UK is really good at this, thanks to all the publicity about what we did during the pandemic, and probably feels we’re in a relatively good place. Well, we’re actually in a worse place than we were three years ago.”

Professor Robin Shattock, from Imperial College, a former chair of VMIC’s board of directors, said he thought the decision to sell had been made on cost grounds. “Suddenly they were worried that they’d built this big white elephant, and they’d be on the hook for the next umpteen years with it ticking over. It probably would have cost £5 million a year — pretty small in defence terms, if you think of it as defence against infectious diseases rather than military defence. But I think that ship has sailed.”

The government recently announced a ten-year partnership with Moderna, the mRNA vaccines manufacturer, to include vaccine manufacturing.

Professor Sandy Douglas, from the Jenner Institute, said that in the early stages of an outbreak, when it is not clear that it will spread, it is not enough to rely on pharmaceutical companies. In particular, he said, a system would be needed that took action when “there’s a 10 per cent chance it’s going to be a problem for the UK, rather than waiting until it’s a 99 per cent chance”.

He also said that to combat unknown future threats the UK needed to rely on more than mRNA. “In 2020, everyone was saying never again,” he said. “But entirely predictably, we’re back in the position where a pandemic is something which is probably not going to happen in this parliament and so it’s off the priority list.

“It’s not really clear to me whether the UK has any system for thinking about emergency commissioning. Is there someone in government who would say, ‘Hello, Oxford, we’d like you to make a vaccine against this quickly?’ I’ve no idea.”

Kate Bingham, former head of the Vaccines Task Force, said she still hoped that the government would seek an alternative mechanism. “The sale of VMIC was a definite loss. But I’m still hoping the government listens to these serious concerns and doubles down on advanced biomanufacturing,” she said. “The chancellor said that the UK life sciences sector could shape and define this century. To do this, we need to reinstate our commitment to working with innovators to scale-up and test new vaccines and biotherapeutics which needs leadership and funds.”

Read more:
UK ‘less prepared for a pandemic now than before Covid’

0
FacebookTwitterGoogle +Pinterest
previous post
Retail sales rise 1.2% as households eat at home more
next post
Colmore BID & Hollie Gazzard Trust launch supporter organisation scheme for not-for-profits 

You may also like

Bernard Arnault Expands Family Influence at LVMH as...

April 19, 2024

World’s biggest offshore wind farm to be built...

December 21, 2023

Brexit checks on fresh food from EU delayed...

August 3, 2023

Anthony Gallo: Connecting Businesses and Realtors to the...

April 1, 2025

House of Lords votes to delay Sunak’s Rwanda...

January 22, 2024

Train drivers at 12 firms will strike on...

September 20, 2022

The Evolution of Digital Marketing: How UK-Based Agencies...

September 20, 2024

Financial Planning for Small Businesses: Avoiding Common Mistakes

October 28, 2024

Understanding the Role of Security Guards in Crime...

May 17, 2024

HRLocker Raises £1.8M in funding round to accelerate growth...

January 12, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump warns of ‘whopping 68% tax increase’ if Senate fails to pass historic bill

      July 1, 2025
    • Tech giants propose under-skin tracking and AI policing in radical justice overhaul

      July 1, 2025
    • UK food prices rise as hot weather slashes harvest yields, say retailers

      July 1, 2025
    • Confidence in short supply among bosses as tax hikes shake business outlook

      July 1, 2025
    • Reeves to cut cash ISA allowance in push to revive UK capital markets

      July 1, 2025
    • Crown Estate matches record profits on windfarm windfall but warns boom is temporary

      July 1, 2025

    Categories

    • Business (8,353)
    • Investing (2,089)
    • Politics (15,882)
    • Stocks (3,180)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved